Yozma

News

  • Admin
  • Apr 02 2025

[Press Release]

Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma

https://www.alphatau.com/single-post/alpha-tau-receives-fda-approval-to-initiate-a-trial-for-patients-with-recurrent-glioblastoma
Previous
What’s New in ULTRA RED: Product Highlights Apr 02 2025
Next
StoreDot Secures EV Charging Patent Shield Apr 15 2025
List